Fentanyl at your door: patient advocacy group is used to promote Insys drug, fentanyl meds

2 months ago, a Senate report suggested that Insys Therapeutics provided $2.5million to a patient advocacy group to influence use and providing of its Subsys opioid painkiller. A new essay in a bioethics blog takes us a step closer to understanding this by following the money. It’s a marketing ploy seen in Big Tobacco, Big Pharma and their combination: Big Pot.